Skip to content

In 2024, Israel became the world’s fourth-largest medical cannabis exporter

Exports jumped almost sevenfold in 2024 • Most of the product headed to Germany via Portugal and Malta

A first publication: while a sharp fight was under way in Israel over the future of cannabis imports from Canada, the export front was posting unprecedented results.

New official figures, first disclosed here in Cannabis Magazine in April 2025, show that in the previous year the quantity of medical cannabis exported from Israel jumped almost sevenfold compared with the year before, from only 625 kilograms in 2023 to about 4.8 tons in 2024.

That jump in exports made Israel the world’s fourth-largest medical cannabis exporter in 2024, after Canada, Portugal and Denmark. That ranking is for 2024 only. It was a significant achievement for a local industry facing many challenges.

As can be seen in the chart published with the Hebrew article, the sharp rise in exports began only in July 2024. Export quantities in the first half of the year were still very small, similar to previous years. The sharp change in trend points to a significant development in the local industry and to the maturing of regulatory processes that had begun years earlier.

Portugal and Malta: waypoints to the German market

On the face of it, the main destination country for Israeli medical cannabis was Portugal, which imported about 2.5 tons from Israel in 2024 (about 51.5% of all Israeli exports). The second country by import volume was Malta, with about 1.6 tons (about a third of total exports). After them came Australia with 572 kilograms (12% of exports) and Germany with 154 kilograms (3.2% of exports). Smaller quantities were exported to France (15 kilograms), Singapore (4 kilograms) and the United Kingdom (1 kilogram).

In practice, the figures conceal a more complicated picture. The final destination of the vast majority, if not all, of the cannabis exported to Portugal and Malta is Germany. Those countries serve only as waypoints for what the industry calls «washing».

Tight regulation: why Israeli cannabis needs to be «washed»

The reason for this bypass is regulatory. Germany requires that cannabis imported into it meet the European cannabis standard, EU-GMP, while the Israeli industry operates according to the Israeli standard, IMC-GMP. As of the time of the article, there were no plants in Israel that held the required European standard.

«In the pharmaceutical world of medicines there is mutual recognition, under which the European authorities recognize the Israeli GMP standard for medicines as equivalent and identical to the European standard,» explains Yoram Eshel, CEO of Cannabilog, which operates an international medical-cannabis logistics operation. «A medicines plant that holds an Israeli standard can export medicines to Europe without needing a European standard. But for some reason, that mutual recognition does not exist when it comes to cannabis.»

In his words: «It is not clear why the Ministry of Health is not acting to obtain mutual recognition for the cannabis standard as well. Unfortunately, to this day that has not happened, and I think it hurts the industry and exports. Why go through another country if it can be done here?»

A record in imports too: more than 24 tons entered Israel

In parallel with the jump in exports, the volume of cannabis imports into Israel also rose significantly in 2024, as Cannabis Magazine had already reported. During the year 24.5 tons of cannabis were imported into Israel, a rise of 42% compared with 2023, when 17.2 tons were imported. That is an all-time record for imports into Israel, slightly above the previous record of 24.3 tons set in 2022.

The vast majority (81.3%) of the cannabis imported into Israel comes from Canada, which exported about 20 tons to Israel in 2024. About another 4.5 tons (18.2%) came from Uganda, and small quantities of about 60 kilograms came from the Netherlands and Portugal.

A built-in contradiction: record exports alongside a fight to restrict imports

The impressive results on the export front arrived at an ironic moment, as a sharp fight was under way in the local industry around Economy Minister Nir Barkat’s decision to impose an anti-dumping levy of up to 165% on cannabis imports from Canada. As had recently been reported, Finance Minister Bezalel Smotrich decided to block the import levy temporarily, arguing that it would have «heavy consequences» for the market and for patients, while Minister Barkat told Smotrich that he intended to ignore the veto that had been imposed and to continue the process.

The developments in exports could supply ammunition to both sides in the fight over the import levy. On one side, local growers can point to the potential in the Israeli industry and to the need to keep it alive. On the other, importers can argue that the growth in exports proves that the local industry is thriving even without tariff protections.

Later figures, from the IMCA situation report for September 2026 (article 289059, published 11 November 2026), show that from January to September 2026 Israel had already exported about 8.60 tons, and 11.9 tons in the 12 months to September 2026. Those figures are larger than the 2024 total of about 4.8 tons, but they do not, on their own, establish a later world ranking.

Enjoyed this article? Add us on GoogleTo see more from Cannabis Magazine in your search results (opens in new tab)